Browsing Tag
PTSD
117 posts
Wisconsin Lawmakers Push To Improve Veterans’ Access to Magic Mushrooms
A bipartisan bill in Wisconsin would help military veterans in the state with post-traumatic stress disorder get easier access to hallucinogenic mushrooms.
U.S. Military Veterans Are Going to Mexico for Psychedelic Treatment
Unable to receive the mental health treatment they desire in their own country, military veterans in the United States are heading south of the border to get what they need.
Massachusetts Governor Unveils Veterans Psychedelics Research Bill
The Healey administration has introduced legislation with several veterans benefits enhancements, including the establishment of a working group to study psychedelics-assisted therapy.
Canadian Senate Calls on Government To Improve Psychedelic Research for Veterans
Psychedelic-assisted therapy shows promise as a treatment for veterans, but more research is needed.
Research Shows Science Behind Psychedelics, Psychotherapy’s Ability To Cause Quick Brain Changes
Human neurons have the capacity to generate their own psychedelic molecule.
New Research Exploring Psychedelics as a Treatment for Anxiety in Cancer Patients
Researchers across the country are studying psychedelics such as psilocybin and MDMA as potential treatments for mental health conditions commonly experienced by cancer patients.
Arizona Department of Revenue Release Cannabis Sales Data for June, July
Data for both medical and recreational cannabis shows a steady decrease in sales since March.
Psychedelics Produce Mental Health Improvements For Special Ops Vets, Study Finds
A newly published analysis showcases the potential offered by psychedelics as a mental health treatment for military veterans.
Two Amendments Relating to Cannabis, Psychedelic Research Added to Defense Bill
One amendment would fund psychedelic clinical trials, and the other would provide treatment options for military veterans suffering from traumatic brain injury and PTSD.
MAPS Study Shows Benefits of Using MDMA To Treat PTSD
MAPS is now on track to proposing MDMA as a treatment for PTSD from the FDA in 2024.